42 Results

People

  1. Downs-Canner
    Downs-Canner
  2. Palomba
    Palomba
  3. Abuhadra
    Abuhadra
  4. Mato
    Mato
  5. Morrow
    Morrow
  6. Plitas
    Plitas
  7. Sevilimedu Veeravalli
    Sevilimedu Veeravalli
  8. Thompson
    Thompson
  9. Arbour
    Arbour
  10. Bott
    Bott

Groups

  1. Department of Medicine (26)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (15)
  4. Solid Tumor Oncology Division (10)
  5. Surgery (10)
  6. Graduate Medical Education (9)
  7. Lymphoma (8)
  8. GME, Medicine (6)
  9. Hematology-Oncology Fellows (6)
  10. Thoracic Oncology (6)
  1. "chemoimmunotherapy"
Formats
  1. Journal Article (23)
  2. Review (6)
  3. Editorial (5)
  4. Correspondence (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Meeting Abstract (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (26)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (15)
  4. Solid Tumor Oncology Division (10)
  5. Surgery (10)
  6. Graduate Medical Education (9)

More Groups

People
  1. Anthony Mato (4)
  2. Lindsey Roeker (4)
  3. Maria Palomba (4)
  4. Stephanie Downs-Canner (4)
  5. George Plitas (3)
  6. Meghan Thompson (3)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Annals of Surgical Oncology (4)
  2. Journal of Thoracic and Cardiovascular Surgery (3)
  3. Annals of Oncology (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (2)
  5. European Journal of Cancer (2)
  6. Haematologica (2)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Springer (5)
  3. Lippincott Williams & Wilkins (3)
  4. Mosby Elsevier (3)
  5. Nature Publishing Group (3)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
    Journal Article

    Skoulidis, F.; Araujo, H. A.; Do, M. T.; Qian, Y.; Sun, X.; Cobo, A. G.; Le, J. T.; Montesion, M.; Palmer, R.; Jahchan, N.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Perioperative immunotherapy for node-negative non-small cell lung cancer — Current evidence and future directions
    Review

    Shahzad, M. H.; Spicer, J. D.; Rusch, V. W.; Kneuertz, P. J.
    Annals of Thoracic Surgery (2024)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Omalizumab for treatment of anti-GD2 antibody-related urticaria
    Journal Article

    Glincher, R.; Lentini-Rivera, A.; Jones, L. A.; D'Andrea, L.; Durney, C.; Kasper, C.; Lin, Y.; Shrager, L.; Markova, A.; Lacouture, M.; more...
    Journal of Pediatric Hematology/Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: Consensus recommendations from the international association for the study of lung cancer
    Review

    Spicer, J. D.; Cascone, T.; Wynes, M. W.; Ahn, M. J.; Dacic, S.; Felip, E.; Forde, P. M.; Higgins, K. A.; Kris, M. G.; Mitsudomi, T.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Commentary: Real-world neoadjuvant immunochemotherapy for lung cancer: Additional data but still many questions
    Editorial

    Rusch, V. W.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save
  • Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer
    Journal Article

    Mai, N.; Chen, J. F.; Rana, S.; Robson, M.; Chandarlapaty, S.; Rosen, E. Y.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Induction therapy for non–small cell lung cancer
    Editorial

    Cooper, A.; Chaft, J. E.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save
  • ASO Author Reflections: Immune-related adverse events during neoadjuvant chemoimmunotherapy for triple-negative breast cancer may influence time to adjuvant radiation
    Editorial

    Myers, S. P.; Downs-Canner, S. M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save